BRAIN INJURY AND PAIN PERCEPTION
Chair: T.W.R. Hansen, Oslo, Norway; N. Marlow, London, UK

  8⁰⁰Special Lecture
How can we reduce brain injury in preterm infants?
A.D. Edwards, London, UK

  8³⁰Monitoring the neonatal brain: How, when and for how long?
L.S. de Vries, Utrecht, The Netherlands

  8⁵⁰Analgetic drugs: Impact on pain perception and brain activity
R. Slater, Oxford, UK

  9¹⁰The use of opioids in the NICU: Navigating between Scylla and Charybdis
J.N. van den Anker, Washington D.C., USA

  9³⁰Panel Discussion

10⁰⁰Coffee Break

10³⁰Poster Prize___

HIDDEN RISKS FOR RETINAL AND CEREBRAL DAMAGE; NEURODEVELOPMENTAL OUTCOME
Chair: A.D. Edwards, London, UK; C. Bührer, Berlin, Germany

10⁴⁵Preventive strategies and up-to-date treatment of severe ROP
A. Hellström, Gothenburg, Sweden

11⁰⁵Hypoxic-ischemic episodes: A hidden risk for brain damage of very
immature preterm infants?
R.J. Martin, Cleveland, USA

11²⁵Neonatal jaundice: A puzzle still unresolved
T.W.R. Hansen, Oslo, Norway

11⁴⁵Outcomes into adulthood for our most immature infants
N. Marlow, London, UK

12⁰⁵Panel Discussion

12³⁰Lunch Break

12⁴⁵Lunch Seminar___

11⁴⁵Partial Personhood: The Newborn in History
M. Obladen, Berlin, Germany

GROWTH FAILURE AND OPTIMAL NUTRITION
Chair: S. Andersson, Helsinki, Finland; D. Haumont, Brussels, Belgium

 13³⁰Preterm nutrition in 2020 - breast milk, probiotics & co: Myths and facts
N. Modi, London, UK

 13⁵⁰Essentials and pitfalls of parenteral nutrition
J. van Goudoever, Amsterdam, The Netherlands

 14¹⁰How to manage postnatal growth failure?
W.W. Hay Jr., Denver, USA

 14³⁰Panel Discussion

15⁰⁰Coffee Break

DRUGS AND OTHER INTERVENTIONS
Chair: M. Hallman, Oulu, Finland; C. Wright, Denver, USA

 15³⁰Pre- and postnatal steroids: A critical appraisal
E.S. Shinwell, Tsfat, Israel

 15⁵⁵Caffeine in preterm infants: Where are we in 2021?
C.C. Roehr, Oxford/Bristol, UK

 16²⁰Panel Discussion

16⁴⁵Conclusion
C.P. Speer, Würzburg, Germany